Results 11 to 20 of about 27,772 (222)
Delayed Diagnosis of a Diffuse Invasive Gastrointestinal Aspergillosis in an Immunocompetent Patient [PDF]
Case Reports in Critical Care, 2020 Invasive aspergillosis represents a clinical picture frequently associated with host’s immunosuppression which usually involves a high morbidity and mortality.
S. Guglielmetti +6 more
doaj +2 more sources
Donor-derived invasive aspergillosis after kidney transplant [PDF]
Medical Mycology Case Reports, 2018 The risk of transmission of infectious diseases from allograft to recipient is well known. Viruses and bacteria are the most frequent causes of transmissible infections.
Maricela Valerio +9 more
doaj +2 more sources
Invasive pulmonary aspergillosis in COVID-19 patients [PDF]
Журнал инфектологии, 2021 A retrospective analysis of the medical data of 12 patients with COVID-19 was performed. For the diagnosis of invasive aspergillosis the international criteria ECMM/ISHAM 2020 were used.
V. G. Gusarov +11 more
doaj +2 more sources
Immunogenetics of invasive aspergillosis [PDF]
Medical Mycology, 2011 Invasive aspergillosis is one of the most important infections in hematopoietic stem cell transplant recipients, with an incidence rate of 5-15% and an associated mortality of 30-60%. It remains unclear why certain patients develop invasive aspergillosis while others, undergoing identical transplant regimen and similar post transplant immunosuppression,
Lamoth Frédéric +2 more
openaire +5 more sources
Disseminated invasive aspergillosis [PDF]
Ghana Medical Journal, 2006 SummaryWe present a case of disseminated invasive aspergillosis in a young male adult with progressive complex gastrointestinal, non-specific peripheral neural and respiratory symptoms and subsequent acute haemorrhagic conjunctivitis and generalized dermatitis.The case emphasizes the difficulty in diagnosing systemic mycosis and a high index of ...
Aleksenko, A, Gyasi, RK, Gyasi, RK
openaire +5 more sources
Invasive Aspergillosis in Transplant Recipients [PDF]
Medicine, 1999 Infections and rejection have long been the leading causes of morbidity and mortality in transplant recipients. Although recent advances in immunosuppression, prophylaxis, and treatment of infections such as cytomegalovirus have resulted in improved outcome in transplant recipients, invasive aspergillosis remains a scourge of transplantation medicine ...
Paterson, David L., Singh, Nina
openaire +6 more sources
Therapeutic Outcome in Invasive Aspergillosis [PDF]
Clinical Infectious Diseases, 1996 A review of series of > or = 4 cases of invasive aspergillosis (total, 1,223 cases) was undertaken to establish the crude mortality and rate of response to therapy with amphotericin B in the major at-risk host groups. In association with pulmonary, sinus, and cerebral aspergillosis in immunocompromised patients, the crude mortality rates were 86%, 66%,
Denning, D.W.; id_orcid
core +7 more sources
Treatment Of Invasive Aspergillosis [PDF]
Namık Kemal Tıp Dergisi, 2018 Invasive aspergillosis (IA) is an infectious disease caused by Aspergillus species, is usually seen in patients with immune deficiency and has been associated with high mortality rate.
İlknur ERDEM +4 more
doaj +1 more source
Pediatric Invasive Aspergillosis [PDF]
Journal of Fungi, 2016 Invasive aspergillosis (IA) is a disease of increasing importance in pediatrics due to growth of the immunocompromised populations at risk and improvements in long-term survival for many of these groups. While general principles of diagnosis and therapy apply similarly across the age spectrum, there are unique considerations for clinicians who care for
Wattier, Rachel L, Ramirez-Avila, Lynn
openaire +5 more sources
European Journal of Medical Research, 2011 Major progress for the management of invasive aspergillosis has come from the introduction of new antifungals since the late 1990s. Although mortality of invasive aspergillosis remains as high as 30-50%.
Karthaus M
doaj +1 more source